Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects
Clinical trial NCT05068947 · COMPLETED
Trial details
- NCT number
- NCT05068947
- Sponsor
- Graviton Bioscience Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2021-10-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.